Portfolio

Through our wide-ranging portfolio, we treat a full spectrum of psychiatric and neurological disorders. We aim to deliver patient-centric solutions by manufacturing and commercialising an extensive scope of products from top quality, cost-effective generics to highly specialised value-added medicines and biologics, all with a growing focus on addressing unmet medical needs through innovation. With our portfolio, we show our commitment to help improve outcomes for patients.

New Chemical Entities and Biologic drugs

Unmet needs

Neuraxpharm is committed to bringing innovative treatment options to our leading CNS portfolio with New Chemical Entities (NCE) or New Biologic Entities (NBE).

A significant addition to our portfolio is a novel anti-CD20 monoclonal antibody  which is a biological treatment option for adult patients with relapsing forms of multiple sclerosis (RMS). This innovative treatment is approved in the United States (US) and the European Union (EU).

Beyond-the-pill (medical devices)

Innovative solutions

Neuraxpharm’s commitment to innovation drives us to complement the pharmaceutical portfolio with medical devices or digital therapeutics designed to enhance the care of patients and their outcomes. For those with epilepsy, Neuraxpharm offers personalized healthcare solutions that address individual medical needs, empowering patients to take greater control over their health by supporting them through a patient-centric approach.

Orphan drugs

Rare treatments

Rare diseases affect a small percentage of the population but for those people the impact of these diseases can be devastating. Neuraxpharm is dedicated to addressing the unique needs of patients with rare, often debilitating or life-threatening CNS disorders, providing hope when few options exist by exploring innovative therapies for conditions such as cALD. Through strategic partnerships with research companies, Neuraxpharm is working to enhance patients’ quality of life and may significantly extend life expectancy

Originator brands

Trusted medicines

Neuraxpharm proudly offers a variety of valuable drugs from well-known brands, meeting the highest quality standards in areas such as child epilepsy and pain management. These drugs have undergone and passed rigorous evaluations to ensure that they are both effective and safe for human use.

Value added medicines

Unique products

Our comprehensive range of value added medicines (differentiated) and high-tech barrier products contribute to addressing unmet healthcare needs of patients with neurological or psychiatric conditions. The differentiation includes different strengths, various pharmaceutical forms and delivery mechanisms, among others, ensuring personalized and effective treatment options for patients.

Neuraxpharm actively promotes its brands of pharmaceuticals for various central nervous system therapeutic areas, including antiepileptics, antipsychotics, antidepressants, tranquilisers, treatments for Parkinson’s disease and for Alzheimer’s disease.

Generics

Standard of care

In addition to our growing portfolio of unique branded pharmaceuticals, Neuraxpharm offers a wide spectrum of high-quality cost-effective therapeutic options developed to improve CNS patients’ quality of life.

Our broad portfolio of marketed generic drugs in Neurology and Psychiatry provides more than 130 molecules, presented in multiple dosage forms and delivery systems, for anxiety, epilepsy, Parkinson’s disease, schizophrenia, depression, Alzheimer’s disease, neuropathic pain etc.

The purpose of our generic medicines is to meet the patient’s and medical specialist’s needs, while ensuring the highest levels of safety, quality and efficacy.

Our goal is to ensure that you find the medicines and consumer health products that best serve your needs and are available in your country. Please access the local websites here for detailed information about the portfolio in each geography.

To complement its CNS product portfolio, Neuraxpharm offers Consumer Healthcare products such as nutraceuticals and probiotics for the maintenance of normal brain, nervous system and psychological functions, while supporting the main activities of the gut-brain axis.

In addition, Neuraxpharm also commercializes Medical Cannabis products in some countries, providing health and mental well-being benefits

Psychiatric Disorders

Neurological Disorders

Mental well-being